Risk Stratification of Patients With Type 2 Long‐QT Syndrome Through Analysis of T‐Wave Morphology
Journal of the American Heart Association · 07.07.2026 · 15 (13)
DOI: 10.1161/jaha.125.048388 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 07.07.2026. Verfasst von Neurys Gómez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Aragón Institute of Engineering Research, IIS Aragón University of Zaragoza Zaragoza Spain. Hauptthemen laut MEDLINE: Long QT Syndrome, Electrocardiography, Heart Conduction System. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Background
Risk stratification in type 2 long‐QT syndrome remains challenging, as QT duration may not fully reflect all underlying arrhythmic vulnerability. We assessed whether an index derived from the T‐wave morphology is associated with cardiac events in a cohort with type 2 long‐QT syndrome.
Methods
We retrospectively and prospectively analyzed 54 genotype‐confirmed patients with type 2 long‐QT syndrome. T‐wave morphology in 8 independent leads was assessed using a warping‐based index, the T‐wave morphology variation (TMV) index, quantifying T‐wave morphologic changes from a general population‐based reference T‐wave. Association with the first lifetime occurrence of a cardiac event, including either syncope or the combined ventricular arrhythmia end point, was tested using univariate and multivariable Cox regression models.
Results
Using the 25th‐percentile threshold (TMV≤−18.41 ms), more negative TMV values indicating greater morphologic changes and a broader or delayed repolarization phase in the T‐wave signal relative to the control, as observed in lead I, were significantly associated with increased risk of cardiac event (hazard ratio [HR], 3.505 [95% CI, 1.673–7.341]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Aragón Institute of Engineering Research, IIS Aragón University of Zaragoza Zaragoza Spain.
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina Zaragoza Spain.
- William Harvey Research Institute, Queen Mary University of London London UK.
- Department of Cardiology, Clinical Sciences Lund University Lund Sweden.
- Department of Cardiology Sahlgrenska University Hospital Gothenburg Sweden.
- Department of Cardiology and Department of Health, Medicine and Caring Sciences Linkoping University Linköping Sweden.
ORCID-Profile: Neurys Gómez, Julia Ramírez, Aleksei A Savelev, Pia Dahlberg, Anneli Svensson, Nina Larsson, Erik Ljungström, Uzma Chaudhry, Juan Pablo Martínez, Pablo Laguna, Pyotr G Platonov
Zitieren
APA
Gómez, N., Ramírez, J., Savelev, A. A., Dahlberg, P., Svensson, A., Larsson, N., Ljungström, E., Chaudhry, U., Martínez, J. P., Laguna, P., & Platonov, P. G. (2026). Risk Stratification of Patients With Type 2 Long‐QT Syndrome Through Analysis of T‐Wave Morphology. Journal of the American Heart Association, 15(13). https://doi.org/10.1161/jaha.125.048388
Vancouver
Gómez N, Ramírez J, Savelev AA, Dahlberg P, Svensson A, Larsson N, et al. Risk Stratification of Patients With Type 2 Long‐QT Syndrome Through Analysis of T‐Wave Morphology. Journal of the American Heart Association. 2026;15(13). doi:10.1161/jaha.125.048388
BibTeX
@article{Gmez2026,
author = {Gómez, Neurys and Ramírez, Julia and Savelev, Aleksei A and Dahlberg, Pia and Svensson, Anneli and Larsson, Nina and Ljungström, Erik and Chaudhry, Uzma and Martínez, Juan Pablo and Laguna, Pablo and Platonov, Pyotr G},
title = {Risk Stratification of Patients With Type 2 Long‐QT Syndrome Through Analysis of T‐Wave Morphology},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {13},
doi = {10.1161/jaha.125.048388}
}
EUVIMED